- Home
- DEI vs VRNA Comparison
DEI vs VRNA Comparison
Compare DEI & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DEI
- VRNA
- Stock Information
- Founded
- DEI 1971
- VRNA 2005
- Country
- DEI United States
- VRNA United Kingdom
- Employees
- DEI N/A
- VRNA N/A
- Industry
- DEI Real Estate Investment Trusts
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- DEI Real Estate
- VRNA Health Care
- Exchange
- DEI Nasdaq
- VRNA Nasdaq
- Market Cap
- DEI 2.5B
- VRNA 8.3B
- IPO Year
- DEI 2006
- VRNA 2017
- Fundamental
- Price
- DEI $15.69
- VRNA $91.89
- Analyst Decision
- DEI Buy
- VRNA Strong Buy
- Analyst Count
- DEI 9
- VRNA 9
- Target Price
- DEI $18.13
- VRNA $112.56
- AVG Volume (30 Days)
- DEI 1.7M
- VRNA 1.1M
- Earning Date
- DEI 08-05-2025
- VRNA 08-07-2025
- Dividend Yield
- DEI 4.87%
- VRNA N/A
- EPS Growth
- DEI N/A
- VRNA N/A
- EPS
- DEI 0.32
- VRNA N/A
- Revenue
- DEI $995,663,000.00
- VRNA $118,535,000.00
- Revenue This Year
- DEI $1.10
- VRNA $891.79
- Revenue Next Year
- DEI $2.30
- VRNA $78.94
- P/E Ratio
- DEI $49.61
- VRNA N/A
- Revenue Growth
- DEI 1.93
- VRNA N/A
- 52 Week Low
- DEI $12.39
- VRNA $15.15
- 52 Week High
- DEI $20.50
- VRNA $99.01
- Technical
- Relative Strength Index (RSI)
- DEI 64.98
- VRNA 55.59
- Support Level
- DEI $14.75
- VRNA $92.88
- Resistance Level
- DEI $15.78
- VRNA $97.44
- Average True Range (ATR)
- DEI 0.40
- VRNA 3.34
- MACD
- DEI 0.08
- VRNA -1.05
- Stochastic Oscillator
- DEI 93.71
- VRNA 9.89
About DEI Douglas Emmett Inc.
Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. It is an owner and operator of office and multifamily properties located in coastal submarkets in Los Angeles and Honolulu. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments, the office segment and the multifamily segment.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.